基因毒性测试市场：按类型、按产品、按最终用户、按地区

预计2024年全球基因毒性测试市场规模为14.1亿美元，预计2031年将达33.3亿美元，2024年至2031年复合年增长率为13.1%。

图：2024 年按地区分類的基因毒性测试市场占有率(%)

全球基因毒性测试市场在历史期间（2019-2028）呈现稳定成长，预计在预测期间（2024-2031）将出现正成长。这主要归因于化学品和消费品安全评估意识的增强。癌症相关疾病的增加、严格的法规（尤其是製药业）以及高性能技术的快速进步等因素是基因毒性测试行业的高影响力驱动因素。然而，与评估基因毒性终点相关的复杂性仍然在一定程度上限制了市场的成长。整体而言，全球基因毒性测试市场预计 2024-2031 年复合年增长率为 13.1%。

市场动态：

由于全球癌症发生率上升，製药和生物技术领域对安全化学品/药物开发的需求不断增长，推动了全球基因毒性测试市场的发展。据世界卫生组织称，到2040年，癌症患者人数预计将达到2,750万，癌症死亡人数将达1,630万。此外，美国食品药物管理局等监管机构强制进行早期安全评估的严格指导方针正在推动其采用。然而，由于临床前评估中解读遗传毒性终点的复杂性以及传统测试方法的技术限制，市场成长可能会受到挑战。领先的市场开拓公司正在投资研发，以开发高效能筛检分析和服务来解决这些问题。

本研究的主要特点

该报告对全球基因毒性测试市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。它。

它还揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。

它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球基因毒性测试市场的主要企业。

本研究涵盖的主要企业包括 Charles River、Thermo Fisher Scientific、F. Hoffmann-La Roche Ltd、Jubilant Life Sciences、Cyprotex、Merck KGaA、Gentronix Limited、BioReliance、Creative Biolabs 等。

该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

本研究报告针对该产业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

透过用于全球基因毒性测试市场分析的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

• 研究目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• 一致的机会地图 (COM)

第三章市场动态、法规及趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 影响分析
• 市场趋势
• 监管场景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第四章全球基因毒性测试市场-冠状病毒（COVID-19）大流行的影响

• 整体影响
• 政府倡议
• COVID-19 对市场的影响

第五章 2019-2031 年全球基因毒性测试市场（按类型）（十亿美元）

• 介绍
• 体外
• 体内

第六章 全球基因毒性测试市场（按产品），2019-2031（十亿美元）

• 介绍
• 试剂
• 消耗品
• 化验
• 服务

第 7 章 全球基因毒性测试市场，按最终用户划分，2019-2031 年（十亿美元）

• 介绍
• 合约研究组织
• 製药公司
• 化学公司
• 其他的

第八章全球基因毒性测试市场，按地区，2019-2031（十亿美元）

• 介绍
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东

第9章 竞争格局

• 公司简介
  • Thermo Fisher Scientific, Inc.
  • WuXi AppTec
  • Charles River Laboratories International
  • Laboratory Corp of America Holdings
  • Eurofins Scientific
  • Jubilant Life Sciences Limited
  • Syngene International Limited
  • Gentronix Ltd.
  • Inotiv Inc.
  • Creative Bioarray
  • MB Research Laboratories
  • Molecular Toxicology, Inc.
  • Toxys
  • GeneTox Worldwide, Inc.

第10章分析师建议

• 上升和下降
• 综合机会图

第十一章 参考文献与调查方法

• 参考
• 调查方法

The global genetic toxicology testing market is estimated to be valued at USD 1.41 Bn in 2024 and is expected to reach USD 3.33 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.1% from 2024 to 2031.

Figure. Genetic Toxicology Testing Market Share (%), By Region 2024

The global genetic toxicology testing market witnessed a steady growth during the historic period (2019-2028) and is projected to see positive gains in the forecast period (2024-2031). This can be primarily attributed to rising awareness about the safety assessment of chemicals and consumer products. Factors such as increasing instances of cancer related diseases, stringent regulations especially in pharmaceutical industry, and rapid advancements of high throughput technologies will serve as high impact rendering drivers for the genetic toxicology testing industry. However, complexities associated with the assessment of genotoxicity endpoints continue to restrict the market growth to a certain extent. Overall, the global genetic toxicology testing market is poised to exhibit a promising 13.1% CAGR during 2024-2031.

Market Dynamics:

The global genetic toxicology testing market is driven by rising incidences of cancer worldwide translating to the increasing demand from the pharmaceutical and biotechnology sectors for safe chemical/drug development. As per WHO, the cancer burden is projected to reach 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. Furthermore, stringent guidelines mandating early safety assessment by regulatory bodies like USFDA, boosts adoption. However, market growth can be challenged due to complexities in deciphering genotoxicity endpoints during preclinical evaluation and technical limitations of few traditional testing methods. Key market players are investing in R&D to develop high throughput screening assays and services to address such issues opening opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global genetic toxicology testing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global Genetic Toxicology Testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Charles River, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Jubilant Life Sciences, Cyprotex, Merck KGaA, Gentronix Limited, BioReliance, Creative Biolabs

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global genetic toxicology testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global genetic toxicology testing market

Detailed Segmentation-

• By Type
  • In Vitro
  • In Vivo
• By Product
  • Reagents
  • Consumables
  • Assays
  • Services
• By End User
  • Contract Research Organizations
  • Pharmaceutical Companies
  • Chemical Companies
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Thermo Fisher Scientific, Inc.
  • WuXi AppTec
  • Charles River Laboratories International
  • Laboratory Corp of America Holdings
  • Eurofins Scientific
  • Jubilant Life Sciences Limited
  • Syngene International Limited
  • Gentronix Ltd.
  • Inotiv Inc.
  • Creative Bioarray
  • MB Research Laboratories
  • Molecular Toxicology, Inc.
  • Toxys
  • GeneTox Worldwide, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Product
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Genetic Toxicology Testing Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Genetic Toxicology Testing Market, By Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• In Vitro
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• In Vivo
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Genetic Toxicology Testing Market, By Product, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Reagents
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Consumables
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Assays
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Services
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Genetic Toxicology Testing Market, By End User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Contract Research Organizations
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Pharmaceutical Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Chemical Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Genetic Toxicology Testing Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Thermo Fisher Scientific, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • WuXi AppTec
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Charles River Laboratories International
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Laboratory Corp of America Holdings
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eurofins Scientific
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Jubilant Life Sciences Limited
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Syngene International Limited
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Gentronix Ltd.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Inotiv Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Creative Bioarray
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • MB Research Laboratories
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Molecular Toxicology, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Toxys
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GeneTox Worldwide, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact